Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

482
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
482
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Methods of Medium Optimization01:28

Methods of Medium Optimization

69
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
69
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

126
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
126

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smac deficiency affects endoplasmic reticulum stress-induced apoptosis in human colon cancer cells.

Molecular and cellular pharmacology·2011
Same author

RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking.

Molecular and cellular pharmacology·2011
Same author

Sulindac Sulfide Differentially Induces Apoptosis in Smac-Proficient and -Deficient Human Colon Cancer Cells.

Molecular and cellular pharmacology·2011
Same author

[Analysis of Differentially Expressed Proteins in Self-Paired Sera of Advanced Non-small Cell Lung Cancer Patients Responsive to Gefinitib.].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2010
Same author

Pooled versus individual genotyping in a breast cancer genome-wide association study.

Genetic epidemiology·2010
Same author

Structural basis for methylarginine-dependent recognition of Aubergine by Tudor.

Genes & development·2010

Related Experiment Video

Updated: Apr 25, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K

Identifying optimal biomarker combinations for treatment selection via a robust kernel method.

Ying Huang1, Youyi Fong

  • 1Fred Hutchinson Cancer Research Center, Public Health Sciences, 1100 Fairview Avenue N., Seattle, Washington 98109-1024, U.S.A.; Department of Biostatistics, University of Washington, Seattle, Washington 98195, U.S.A.

Biometrics
|August 16, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to find the best biomarker combinations for personalized treatment selection, aiming to reduce disease burden effectively. The approach uses a novel penalized minimization technique based on the difference of convex functions algorithm (DCA).

Keywords:
Biomarker combinationKernel methodRandomized trialRobustSupport vector machineTreatment selection

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K

Related Experiment Videos

Last Updated: Apr 25, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Personalized Medicine

Background:

  • Treatment-selection markers optimize therapy choice for better patient outcomes.
  • Effective marker-based rules can reduce disease burden cost-effectively.
  • Identifying optimal biomarker combinations is crucial for personalized medicine.

Purpose of the Study:

  • To develop a method for identifying optimal linear and nonlinear biomarker combinations for treatment selection.
  • To minimize the total population burden from disease and treatment using data from randomized trials.
  • To propose a novel penalized minimization method based on the difference of convex functions algorithm (DCA).

Main Methods:

  • Framing the objective as minimizing a weighted sum of 0-1 loss.
  • Proposing a novel penalized minimization method using the difference of convex functions algorithm (DCA).
  • Utilizing a kernel property for flexible modeling of linear and nonlinear marker combinations.

Main Results:

  • The proposed DCA-based method identifies optimal linear and nonlinear biomarker combinations.
  • The method allows flexible modeling of marker combinations due to its kernel property.
  • Comparison with logistic regression and weighted support vector machines demonstrates performance.

Conclusions:

  • The novel DCA-based penalized minimization method effectively identifies optimal biomarker combinations for treatment selection.
  • This approach offers a flexible way to model complex linear and nonlinear marker relationships.
  • Application to an HIV vaccine trial highlights its utility in real-world scenarios for personalized vaccination strategies.